Company intelligence / Profile preview

National Heart

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

National Heart Centre Singapore (NHCS) is a specialist medical center and a regional referral center for cardiovascular diseases. As a member of the SingHealth group, it integrates clinical care with robust research and development programs focused on heart health. NHCS operates a dedicated National Heart Research Institute Singapore (NHRIS) which conducts translational research in areas such as regenerative medicine, genetics, and metabolic heart disease. The center provides a comprehensive suite of cardiac services, including complex surgical procedures, interventional cardiology, and specialized outpatient clinics.

Therapeutic areas: Cardiovascular
Modalities: Cell therapyGene therapySmall moleculeMedical Device
Industry: Academic Hospital/University/Research

Partnerships

Duke-NUS Medical SchoolA*STARNational University Health System

Beyond the preview

Go deeper on National Heart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Heart.